Membrane Protein-Based Small Molecule Drug Discovery Service
- Novel drug development targeting membrane proteins such as GPCRs, ion channels, and ABC transporters.
- Target engagement validation and mechanistic studies for small-molecule candidates.
- High-throughput screening and structural optimization of small-molecule lead compounds.
- Structure-based drug design enabled by in-depth structural studies of challenging membrane protein targets.
Membrane Protein-Based Small Molecule Drug Discovery Service refers to a comprehensive technical solution focused on membrane proteins as core targets, utilizing multiple technology platforms to conduct small molecule screening, validation, and optimization. This service is designed to support research institutions and pharmaceutical companies in efficiently identifying lead compounds with drug-like potential, and is particularly suited for key membrane protein targets such as GPCRs, ion channels, transporters, and membrane-associated enzymes.
de Jong E. Kocer A. Membranes. 2023.
Membrane proteins play essential roles in cellular processes and disease progression, making them one of the most critical target classes in modern drug discovery. Statistics indicate that over 60% of known drug targets are membrane proteins. Among them, transmembrane receptors such as G protein-coupled receptors (GPCRs) represent approximately one-third of all small molecule drug targets and are pivotal in the development of approved therapeutics. In recent decades, advancements in biotechnology—particularly high-resolution structural analysis and biophysical screening techniques—have significantly accelerated membrane protein-based drug discovery.
MtoZ Biolabs offers Membrane Protein-Based Small Molecule Drug Discovery Service that spans membrane protein extraction and purification, structural analysis, and membrane protein–ligand interaction studies. This service is designed to help clients identify small molecule candidates with strong druggability potential targeting membrane proteins.
Analysis Workflow
The core workflow of Membrane Protein-Based Small Molecule Drug Discovery Service includes the following steps:
1. Membrane Protein Expression and Purification
Appropriate expression systems are selected to produce high-quality, functional membrane protein samples.
2. Structural Analysis
Techniques such as cryo-electron microscopy (Cryo-EM), X-ray crystallography, or nuclear magnetic resonance (NMR) are employed to resolve the three-dimensional structure of membrane proteins, providing a foundation for molecular docking and target analysis.
3. Small Molecule Screening
High-throughput screening platforms are used to perform fragment-based or small molecule compound screening.
4. Binding Analysis and Validation
Surface plasmon resonance (SPR), mass spectrometry (MS), and other technologies are applied to assess the binding affinity and specificity between small molecules and target membrane proteins.
5. Lead Optimization Recommendations
Based on structural models and interaction kinetics, tailored suggestions for lead compound optimization and rational drug design are provided.
Service Advantages
1. Advanced Analysis Platform: MtoZ Biolabs established an advanced Membrane Protein-Based Small Molecule Drug Discovery Service platform, guaranteeing reliable, fast, and highly accurate analysis service.
2. One-Time-Charge: Our pricing is transparent, no hidden fees or additional costs.
3. High-Data-Quality: Deep data coverage with strict data quality control. AI-powered bioinformatics platform integrates all Membrane Protein-Based Small Molecule Drug Discovery data, providing clients with a comprehensive data report.
4. High-Quality Membrane Protein Preparation: Utilizes optimized workflows to produce membrane proteins with high purity, excellent stability, and preserved native functionality.
5. Customized Research Strategies: Offers tailored study designs based on specific project needs, delivering a highly flexible and client-oriented service model.
Services at MtoZ Biolabs
MtoZ Biolabs’ Membrane Protein-Based Small Molecule Drug Discovery Service is built upon the efficient extraction and purification of membrane proteins, followed by high-resolution structural elucidation using techniques such as cryo-EM, X-ray crystallography, and NMR. By integrating structural insights with advanced biophysical and biochemical analysis platforms, we enable the screening, validation, and optimization of candidate small-molecule drugs targeting membrane proteins.
MtoZ Biolabs, an integrated Chromatography and Mass Spectrometry (MS) Services Provider, provides advanced proteomics, metabolomics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. Our ultimate aim is to provide more rapid, high-throughput, and cost-effective analysis, with exceptional data quality and minimal sample consumption.
Applications
Applications of Membrane Protein-Based Small Molecule Drug Discovery Service include, but are not limited to:
Deliverables
1. Comprehensive Experimental Details
2. Materials, Instruments, and Methods
3. Total Ion Chromatogram & Quality Control Assessment (project-dependent)
4. Data Analysis, Preprocessing, and Estimation (project-dependent)
5. Bioinformatics Analysis
6. Raw Data Files
Related Services
Membrane and Membrane Protein Extraction Service
Membrane Protein Structure Determination Service
How to order?
